Antioxidants, Helicobacter pylori and stomach cancer in Venezuela.
A randomized chemoprevention trial on precancerous lesions of the stomach is being conducted in Tachira State, Venezuela. The aims of the study are to evaluate the efficacy of vitamin supplementation in preventing the progression rate of precancerous lesions. Here we report on the pilot phase of the study in which two antioxidant preparations were evaluated on their ability to raise antioxidant levels in plasma and in gastric juice. The study aimed also to determine the antibiotic sensitivity profiles of Helicobacter pylori isolates prevalent in the area. Forty-three subjects with precancerous lesions (chronic gastritis, chronic atrophic gastritis, intestinal metaplasia and dysplasia) of the stomach were randomized to one of two antioxidant treatments. Treatment 1 (250 mg of standard vitamin C, 200 mg of vitamin E and 6 mg of beta-carotene three times a day) or treatment 2 (150 mg of standard vitamin C, 500 mg of slow release vitamin C, 75 mg of vitamin E and 15 mg of beta-carotene once a day) for 7 days. Blood levels of total vitamin C, beta-carotene and alpha-tocopherol and gastric juice levels of ascorbic acid and total vitamin C were measured before and after treatment on day 8. Both treatments increased the plasma levels of total vitamin C, beta-carotene and alpha-tocopherol/cholesterol but not those of ascorbic acid or total vitamin C in gastric juice. Treatment 1 was the best choice and resulted in a greater increase in the plasma levels of beta-carotene and alpha-tocopherol. H. pylori was cultured from 90% of the gastric biopsies; 35 isolates were identified which were highly resistant to metronidazole, a front-line antibiotic recommended against H. pylori in other settings.
de Sanjosé
S
S
Servei d'Epidemiologia i Registre del Cancer, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona, Spain.
Muñoz
N
N
Sobala
G
G
Vivas
J
J
Peraza
S
S
Cano
E
E
Castro
D
D
Sanchez
V
V
Andrade
O
O
Tompkins
D
D
Schorah
C J
CJ
Axon
A T
AT
Benz
M
M
Oliver
W
W
D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000032:analysis / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D002338:Carotenoids / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D018890:Chemoprevention; D002908:Chronic Disease; D018450:Disease Progression; D005260:Female; D005750:Gastric Juice / Q000737:chemistry; D005756:Gastritis / Q000188:drug therapy; D005757:Gastritis, Atrophic / Q000188:drug therapy; D016481:Helicobacter Infections / Q000517:prevention & control*; D016480:Helicobacter pylori / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008679:Metaplasia; D008875:Middle Aged; D010865:Pilot Projects; D011230:Precancerous Conditions / Q000517:prevention & control*; D013274:Stomach Neoplasms / Q000517:prevention & control*; D014687:Venezuela; D014810:Vitamin E / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D014815:Vitamins / Q000032:analysis / Q000097:blood / Q000627:therapeutic use*; D019207:beta Carotene
D000975:Antioxidants; D014815:Vitamins; D019207:beta Carotene; D014810:Vitamin E; D002338:Carotenoids; D001205:Ascorbic Acid